Small cap movers: Upsurges for Bradda Head and Helium One but disappointment for SDX


Shares in Bradda Head Holdings Ltd (AIM:BHL) grew by a third this week after the company hired Terravision Exploration to conduct geophysical programmes across three lithium projects in Arizona.

Terravision will shoot ground-penetrating radar (GPR), referred to as ‘GPRplus’, at Bradda’s Burro Creek, Wikieup and San Domingo projects.

The GPR work will assist in upcoming exploration efforts by optimising drill plans, to avoid unnecessary drilling meterage and ultimately to accelerate the overall programme.

Elsewhere in the resource sector, Helium One Global Ltd (AIM:HE1) rallied 27% to 15.6p as it got into a Robert the Bruce vibe.

With the rapid spudding of the Tai-2 well the explorer is not jumping to Plan B, it’s repeating Plan A. The company began drilling Tai-2 just over a week since the non-result of Tai-1 disappointed the firm’s retail investor base that has bought up the shares strongly in the months following its AIM market float in December.

Tai-2 aims to test the same targets that provided evidence of a helium system in Tai-1 but could not be evaluated properly due to poor hole conditions. It is located only 20 metres from Tai-1 and is being drilled from the same drill pad, which saves costs and allows a quick turnaround.

SDX Energy PLC (AIM:SDX, FRA:3KX, OTC:SDXEF), down 23% at 11.75p, was another oiler in the casualty ward in the wake of drilling news.

The HA-1X exploration well on the Hanut prospect spudded on 4 August and reached the target depth of 6,000ft on 17 August, SDX told investors.

The primary target for HA-1X was the Basal Kafr El Sheikh sand at about 5,200ft. The well, however, found that the Basal Kafr El Sheikh sand had been eroded at this location. While drilling to target depth, good quality sands were found at the Qawasim level; however they were not charged with gas.

Novacyt SA, the clinical diagnostics company, is the definition of a volatile stock and it was on the move again this week, rising 35% to 402.05p after its half-year update. That’s still less than half its 12-month high of 1.194p set in October 2020 but four times its pre-pandemic level.

Novacyt’s revenue for the first half of 2021 increased over 50% to GBP94.7 million, compared to GBP63.3 million for the first half of 2020. Of this total revenue, GBP54 million came from a mixture of overseas sales and a growing UK private testing market, leading to non-DHSC (Department of Health and Social Care) revenue growing 20% year-on-year.

Much of the excitement over Novacyt shares has been caused by its COVID-19 tests and there was more news on that front with Primerdesign, a wholly-owned subsidiary of Novacyt, winning a new contract under the PHE National Microbiology Framework, effective immediately, for the supply of PROmate COVID-19 tests to the NHS.

Diamonds are forever but finding the sparkling rocks is tricky although this week Bluerock Diamonds PLC (AIM:BRD) made it look easy. At the beginning of the week it said it discovered a 58.6 carat diamond at the Kareevlei mine in South Africa, just one week on from a 21.56 carat diamond find from the same mine. Then, on Thursday, it announced the discovery of a 14.3 carat stone, the third high-quality large stone in August to date.


Please enter your comment!
Please enter your name here